Skip to main content
OpenTrials

Clinical trial condition

Turcot syndrome

Explore clinical trials studying Turcot syndrome. Study availability and eligibility vary by location and protocol.

45 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Turcot syndrome trial results

Recruiting

A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

NCT07213609

Conditions
Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +22 more
Locations
  • GSK Investigational Site Aurora, Colorado, United States
  • GSK Investigational Site Detroit, Michigan, United States
  • GSK Investigational Site Canton, Ohio, United States
  • GSK Investigational Site Nashville, Tennessee, United States
View all 22 locations
View Trial Details
Recruiting

Lynch Syndrome X-Talk of Enteral Mucosa With Immune System

NCT06708429

Conditions
Colonic Diseases, Colorectal Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, +49 more
Locations
  • Beckman Research Institute at City of Hope Monrovia, California, United States
  • Gastronterology and Gastrointestinal Endoscopy Unit, IRCCS San Raffaele Hospital Milan, Lombardy, Italy
  • Dipartimento di Chirurgia Oncologica e Dipartimento di Oncologia Sperimentale Istituto Nazionale Tumori Milan, MI, Italy
  • Dipartimento di controllo qualità e rischio chimico biologico, AOOR Villa Sofia Cervello Palermo, PM, Italy
View Trial Details
Recruiting

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

NCT06362369

Conditions
ALK Genomic Tumor Aberrations, Adenocarcinoma, Adenoma, +69 more
Locations
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Florida Cancer Specialists Lake Mary, Florida, United States
  • Dartmouth Hitchcock Lebanon, New Hampshire, United States
  • Brown University Health Cancer Institute Providence, Rhode Island, United States
View Trial Details
Recruiting

EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

NCT07262619

Conditions
Advanced Solid Tumors, Endometrial Cancer, Endometrial Neoplasms, +21 more
Locations
  • Morristown Medical Center Morristown, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center (MSKCC) New York, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • GenesisCare North Shore (Oncology) Saint Leonards, New South Wales, Australia
View Trial Details
Recruiting

Liquid Biopsy and Machine Learning for Early Colorectal Cancer, Adenomas, Lynch Cancers, and Residual Disease Detection

NCT07450612

Conditions
Adenoma Colon, Adenoma Colon Polyp, Colo-rectal Cancer, +37 more
Locations
  • Gastronterology and Gastrointestinal Endoscopy Unit, IRCCS San Raffaele Hospital Milan, Lombardy, Italy
  • Prof Giulia Martina Cavestro, MD PhD Milan, Lombardy, Italy
  • San Raffaele Scientific Institute, Gastroenterology and Gastrointestinal Endoscopy Unit Milan, Lombardy, Italy
  • Dipartimento di Chirurgia Oncologica e Dipartimento di Oncologia Sperimentale Istituto Nazionale Tumori Milan, MI, Italy
View Trial Details
Recruiting

177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors

NCT06305962

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +46 more
Locations
  • Nepean Hospital Kingswood, New South Wales, Australia
  • Wollongong Hospital Wollongong, New South Wales, Australia
  • Gold Coast University Hospital Southport, Queensland, Australia
  • Cancer Research SA (CRSA) Adelaide, South Australia, Australia
View Trial Details

Related conditions